Characterization of the Infectious Salmon Anemia Virus Fusion Protein

ABSTRACT Infectious salmon anemia virus (ISAV) is an orthomyxovirus causing serious disease in Atlantic salmon ( Salmo salar L.). This study presents the characterization of the ISAV 50-kDa glycoprotein encoded by segment 5, here termed the viral membrane fusion protein (F). This is the first descri...

Full description

Bibliographic Details
Published in:Journal of Virology
Main Authors: Aspehaug, Vidar, Mikalsen, Aase B., Snow, Michael, Biering, Eirik, Villoing, Stéphane
Format: Article in Journal/Newspaper
Language:English
Published: American Society for Microbiology 2005
Subjects:
Online Access:http://dx.doi.org/10.1128/jvi.79.19.12544-12553.2005
https://journals.asm.org/doi/pdf/10.1128/JVI.79.19.12544-12553.2005
Description
Summary:ABSTRACT Infectious salmon anemia virus (ISAV) is an orthomyxovirus causing serious disease in Atlantic salmon ( Salmo salar L.). This study presents the characterization of the ISAV 50-kDa glycoprotein encoded by segment 5, here termed the viral membrane fusion protein (F). This is the first description of a separate orthomyxovirus F protein, and to our knowledge, the first pH-dependent separate viral F protein described. The ISAV F protein is synthesized as a precursor protein, F 0 , that is proteolytically cleaved to F 1 and F 2 , which are held together by disulfide bridges. The cleaved protein is in a metastable, fusion-activated state that can be triggered by low pH, high temperature, or a high concentration of urea. Cell-cell fusion can be initiated by treatment with trypsin and low pH of ISAV-infected cells and of transfected cells expressing F, although the coexpression of ISAV HE significantly improves fusion. Fusion is initiated at pH 5.4 to 5.6, and the fusion process is coincident with the trimerization of the F protein, or most likely a stabilization of the trimer, suggesting that it represents the formation of the fusogenic structure. Exposure to trypsin and a low pH prior to infection inactivated the virus, demonstrating the nonreversibility of this conformational change. Sequence analyses identified a potential coiled coil and a fusion peptide. Size estimates of F 1 and F 2 and the localization of the putative fusion peptide and theoretical trypsin cleavage sites suggest that the proteolytic cleavage site is after residue K 276 in the protein sequence.